Cargando…

Management and Prognosis of Patients with Recurrent or Persistent/Progressive Uterine Carcinosarcoma

Uterine carcinosarcoma (UCS) is a highly aggressive gynecologic malignancy. Recurrent or persistent/progressive disease is usually fatal. We aimed to investigate the management and prognosis of these patients. Clinical records of UCS patients from June 1987 to April 2020 were retrospectively reviewe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tung, Hsiu-Jung, Chiang, Chi-Yuan, Chang, Wei-Yang, Wu, Ren-Chin, Huang, Huei-Jean, Yang, Lan-Yan, Lin, Chiao-Yun, Wang, Chun-Chieh, Chao, Angel, Lai, Chyong-Huey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600185/ https://www.ncbi.nlm.nih.gov/pubmed/36290878 http://dx.doi.org/10.3390/curroncol29100601

Ejemplares similares

MicroRNAs as Predictors of Future Uterine Malignancy in Endometrial Hyperplasia without Atypia
por: Lin, Chiao-Yun, et al.
Publicado: (2022)

Rare Subtype of Endometrial Cancer: Undifferentiated/Dedifferentiated Endometrial Carcinoma, from Genetic Aspects to Clinical Practice
por: Tung, Hsiu-Jung, et al.
Publicado: (2022)

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
por: Hunt, Jonathan T., et al.
Publicado: (2021)

Identification of distinct molecular subtypes of uterine carcinosarcoma
por: An, Yang, et al.
Publicado: (2017)

Targeting the TGFβ pathway in uterine carcinosarcoma
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2020)

Trends of uterine carcinosarcoma in the United States
por: Matsuo, Koji, et al.
Publicado: (2018)

Inhibition of BIRC2 Sensitizes α7-HPV-Related Cervical Squamous Cell Carcinoma to Chemotherapy
por: Lin, Chiao-Yun, et al.
Publicado: (2021)

OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma
por: An, Yang, et al.
Publicado: (2020)

Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
por: Gonzalez dos Anjos, Laura, et al.
Publicado: (2018)

Small cell neuroendocrine carcinoma of the cervix: From molecular basis to therapeutic advances
por: Chao, Angel, et al.
Publicado: (2023)

Long-term recurrence-free survival in a patient with stage IVB uterine carcinosarcoma
por: Yoon, Gun, et al.
Publicado: (2011)

Uterine Carcinosarcoma in a Patient with Didelphys Uterus
por: Iavazzo, C., et al.
Publicado: (2013)

Role of TGF-β signaling in uterine carcinosarcoma
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2015)

Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas
por: Sertier, Anne-Sophie, et al.
Publicado: (2023)

Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
por: Lodetti, Giorgia, et al.
Publicado: (2023)

The prognostic significance of the heterologous component in uterine carcinosarcomas
por: Can, Behzat, et al.
Publicado: (2023)

In‐depth molecular profiling of the biphasic components of uterine carcinosarcomas
por: McConechy, Melissa K, et al.
Publicado: (2015)

Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011)

Carcinosarcoma of the uterine cervix arising from Müllerian ducts
por: Kim, Myounghwan, et al.
Publicado: (2015)

Port-Site Metastasis of Uterine Carcinosarcoma after Laparoscopy
por: Tan, Zhen, et al.
Publicado: (2017)

Brain Metastasis in a Young Patient with Uterine Carcinosarcoma
por: Katiyar, Vatsala, et al.
Publicado: (2019)

Clinical utility of CA-125 in the management of uterine carcinosarcoma
por: Matsuo, Koji, et al.
Publicado: (2018)

Uterine Carcinosarcoma: A Case Report and Literature Review
por: Kord, Ali, et al.
Publicado: (2020)

The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
por: Moukarzel, Lea A., et al.
Publicado: (2021)

Prognostic value of the TCGA molecular classification in uterine carcinosarcoma
por: Travaglino, Antonio, et al.
Publicado: (2021)

Clostridium and Bacteroides bacteremia as initial presentation of uterine carcinosarcoma
por: Imo, Chinonye S., et al.
Publicado: (2022)

Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival
por: Gracia, Myriam, et al.
Publicado: (2023)

HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
por: McNamara, Blair, et al.
Publicado: (2023)

Recurrent Parotid Carcinosarcoma in an Asymptomatic Patient
por: Mansour, Joshua, et al.
Publicado: (2016)

The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma
por: Park, Hae Jin, et al.
Publicado: (2011)

Adjuvant Treatment Modalities, Prognostic Predictors and Outcomes of Uterine Carcinosarcomas
por: Gungorduk, Kemal, et al.
Publicado: (2015)

Role of MRI in uterine didelphys with co-existing endometrial carcinosarcoma
por: McGregor, Jill, et al.
Publicado: (2018)

Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives
por: Vitale, Salvatore Giovanni, et al.
Publicado: (2017)

Cancer antigen 125 is associated with disease status in uterine carcinosarcoma
por: Ross, Malcolm Strachan, et al.
Publicado: (2019)

The prevalence and prognostic impact of tumor-infiltrating lymphocytes in uterine carcinosarcoma
por: da Silva, Jesse Lopes, et al.
Publicado: (2021)

Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation
por: Markert, Tahireh, et al.
Publicado: (2022)

Inter-component immunohistochemical assessment of proliferative markers in uterine carcinosarcoma
por: Pyra, Andrzej, et al.
Publicado: (2022)

Uterine carcinosarcoma: A 10-year single institution experience
por: Terblanche, Leana, et al.
Publicado: (2022)

Feline uterine carcinosarcoma infiltrated with osteoclast-like giant cells
por: MURAKAMI, Mami, et al.
Publicado: (2022)

Pure abscopal effect in a patient with advanced uterine carcinosarcoma
por: Okamoto, Kazuhiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ia5rrq8n15vqqjhe4rbk6ve5m0